Publications by authors named "H Farzin"

Article Synopsis
  • Psilocybin-assisted therapy shows promise in relieving existential distress for patients with serious illnesses, but access remains a challenge in palliative care settings in Canada despite recent legal changes.
  • A study involving 16 palliative care professionals revealed their interest in the therapy, but also highlighted concerns such as the need for more education, research, refined protocols, and clarified eligibility criteria.
  • The findings suggest that the acceptability of psilocybin therapy among healthcare providers is crucial for its successful integration into practice, indicating that developing clear guidelines could facilitate wider access and usage.
View Article and Find Full Text PDF

Chemotherapy-induced peripheral neuropathy (CIPN) remains a clinical challenge for up to 80% of breast cancer survivors. In an open-label study, participants underwent three interventions: standard care (duloxetine) for 1 month (Phase 1), oral cannabidiol (CBD) for 2 months (Phase 2), and CBD plus multi-modal exercise (MME) for another 2 months (Phase 3). Clinical outcomes and gut microbiota composition were assessed at baseline and after each phase.

View Article and Find Full Text PDF

Background: Infectious bronchitis virus (IBV), Newcastle disease virus (NDV), and avian influenza virus (AIV) H9N2 are major viral pathogens in broiler respiratory disease.

Aims: Following a respiratory disease outbreak and economic losses in eastern Iran 2020-2021, we investigated the role of major viral pathogens and the implemented vaccination programs.

Methods: Thirty-six respiratory disease affected broiler flocks in South Khorasan province were sampled, molecularly tested, and coinfections were investigated.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examines how acceptable psilocybin-assisted therapy is for treating existential distress in terminally ill patients, revealing significant public interest in its medical use in Canada.
  • - An online survey found that 79.3% of respondents viewed the therapy as a reasonable option, with 84.8% supporting public health coverage for the treatment, and 63.3% in favor of legalizing psilocybin for medical use.
  • - Factors such as prior psilocybin use, exposure to palliative care, and progressive political views led to more positive attitudes toward the therapy, indicating a strong potential for its integration into end-of-life care.
View Article and Find Full Text PDF

Concurrent with an increase in the human population on the earth, more than ever, the creation of energy and maintenance of health is necessary, and nowadays, various sources of energy supply are being developed. The general global view in this regard is to provide protein and energy from available and cheap sources. Iran is no exception to this general rule, only in the field of ensuring the health of livestock resources every year, about 10 tons of peptone is needed for producing clostridial vaccines.

View Article and Find Full Text PDF